This inventor holds 1 USPTO granted patent. Top assignee: Universität Autonoma De Barcelona. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ivet Elias Puigdomènech: Innovator in Gene Therapy
Introduction
Ivet Elias Puigdomènech is a notable inventor based in Matadepera, Spain. He has made significant contributions to the field of gene therapy, particularly through his work on the Fibroblast Growth Factor 21 (FGF21). His innovative approach has the potential to impact various medical applications.
Latest Patents
Ivet holds a patent for his groundbreaking work on FGF21 gene therapy. This patent represents a significant advancement in the understanding and treatment of metabolic disorders. His research is aimed at harnessing the therapeutic potential of FGF21 to improve patient outcomes.
Career Highlights
Ivet is affiliated with the Universitat Autònoma de Barcelona, where he conducts his research and development. His academic background and ongoing research contribute to the advancement of gene therapy techniques. His dedication to innovation in this field is evident through his patent and ongoing projects.
Collaborations
Ivet collaborates with Maria Fàtima Bosch Tubert, who is also involved in research related to gene therapy. Their partnership exemplifies the collaborative spirit in scientific research, fostering innovation and discovery.
Conclusion
Ivet Elias Puigdomènech is a pioneering inventor whose work in FGF21 gene therapy holds promise for future medical advancements. His contributions to the field are noteworthy and reflect his commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile